MINNEAPOLIS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2025 financial results will be released after the market closes on Tuesday, February 17, 2026. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on February 17, 2026, to discuss the results of th ...

Tactile Systems Technology, Inc. (TCMD) Investment Analysis TCMD's recent stock price decline of approximately 4.22% over the past 30 days and 5.25% in the last 10 days may present a buying opportunity for investors. The company has a Piotroski Score of 8, indicating strong financial health and robust fundamentals. Analysts have set a target price of $32.50 for TCMD, suggesting significant growth potential and making it an attractive investment option.Tactile Systems Technology, Inc. (NASDAQ: TCMD) is a med ...

Summary of Tactile Medical Conference Call Company Overview - **Company**: Tactile Medical - **Industry**: Medical Technology, specifically focusing on lymphedema and airway clearance products Key Points Financial Performance - Q3 results showed strong performance with beats and raises in both lymphedema and airway clearance businesses [3][4] - The company is in a healthy financial position with cash reserves, retired debt, and stock buybacks [4] Market Opportunity - The lymphedema and bronchiectasis markets are under-penetrated, presenting significant growth opportunities [3][4] - There are approximately 20 million people in the U.S. with lymphedema, but only 2 million are diagnosed, and less than 10% are on medical device therapy [34][35] Strategic Focus - The company is focusing on improving access to care, product innovation, and lifetime value [4] - Investments in CRM and sales force restructuring are aimed at enhancing sales productivity [7][9][10] Product Portfolio - The **Nimble** pump has been successful, leading to market leadership in both basic and advanced pump categories [21][22] - The **FlexiTouch** product is expected to benefit from new reimbursement policies, transitioning from a headwind to a tailwind [14][16][17] Reimbursement Changes - Transition from Local Coverage Determination (LCD) to National Coverage Determination (NCD) is expected to provide a more favorable reimbursement environment [12][14] - The company anticipates seeing positive impacts from these changes in Q4 [16] Innovation and Development - Plans for next-generation products, including enhancements to the AffloVest, are underway, with a focus on portability and connectivity [53] - The company is actively working on expanding its product offerings and improving existing products [22][63] Market Dynamics - The airway clearance market, particularly the AffloVest, is also performing well, with expectations of continued double-digit growth [46][50] - The company is leveraging partnerships with top DMEs to enhance product distribution and awareness [42][44] Future Outlook - The company expects to maintain growth in line with market trends, projecting revenue growth of around 10% for 2026 [54][55] - Continued investments in technology and infrastructure are planned, with a focus on achieving operational leverage [55][57] Capital Allocation - The company has paid down debt and is open to share repurchase programs while maintaining sufficient capital for internal growth and strategic opportunities [57][58] Additional Insights - The company is actively working to raise awareness about lymphedema and improve diagnosis rates, which is crucial for market penetration [36][37] - The competitive landscape for head and neck lymphedema treatment is favorable for Tactile Medical, as it holds unique coverage advantages [33][34] This summary encapsulates the key insights and strategic directions discussed during the Tactile Medical conference call, highlighting the company's strong market position and growth potential in the medical technology sector.

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, with the aim of buying high and selling higher, capitalizing on established price movements [1] Company Overview: Tactile Systems Technology (TCMD) - TCMD currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for potential outperformance in the market [3] Performance Metrics - TCMD shares have increased by 8.44% over the past week, while the Zacks Medical - Instruments industry remained flat during the same period [5] - Over the past quarter, TCMD shares have surged by 93.22%, and they have gained 36.98% over the last year, significantly outperforming the S&P 500, which rose by 5.43% and 14.79% respectively [6] - The average 20-day trading volume for TCMD is 753,286 shares, indicating a bullish trend as the stock is rising with above-average volume [7] Earnings Outlook - In the last two months, three earnings estimates for TCMD have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $0.62 to $0.80 [9] - For the next fiscal year, three estimates have also moved higher, reflecting positive sentiment regarding the company's earnings potential [9] Conclusion - Given the strong performance metrics and positive earnings outlook, TCMD is identified as a promising investment opportunity with a Momentum Score of A and a Zacks Rank of 2 (Buy) [11]

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Tactile Systems Technology (TCMD) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.Tactile Systems Technology is one of 947 individual stocks in the Medical sector. Collectively, these companies sit at #3 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from ...

Group 1: Stock Highlights - Tactile Systems Technology (TCMD) has seen a 29% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Naspers (NPSNY) has experienced a 20.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - SB Financial Group (SBFG) has recorded a 5.4% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [3] - OP Bancorp (OPBK) has seen a 4.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [4] - Sony (SONY) has experienced a 4.4% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [4]

Core Insights - Tactile Systems Technology, Inc. will participate in the Piper Sandler 37th Annual Healthcare Conference from December 2 to 4, 2025, with a fireside chat scheduled for December 2 at 8:00 a.m. Central Time [1] Company Overview - Tactile Medical is a leader in developing and marketing at-home therapies for chronic conditions such as lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease, aiming to improve patients' quality of life [3] - The company collaborates with clinicians to enhance clinical evidence, raise awareness, increase access to care, reduce healthcare costs, and improve the quality of life for tens of thousands of patients annually [3]

Tactile Systems Technology (TCMD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the sy ...

Group 1 - Tactile Systems Technology, Inc. (TCMD) has seen a 29% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Harmony Gold Mining Company Limited (HMY) has experienced a 12.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Robinhood Markets, Inc. (HOOD) has reported a 21.9% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - Fabrinet (FN) has seen an 8.6% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - TE Connectivity plc (TEL) has experienced a 7.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [3]

Tactile Systems Technology Inc (NASDAQ:TCMD) reported upbeat third-quarter earnings and raised FY2025 sales guidance on Monday.Tactile Systems Tech reported quarterly earnings of 36 cents per share which beat the analyst consensus estimate of 17 cents per share. The company reported quarterly sales of $85.755 million which beat the analyst consensus estimate of $79.306 million.Tactile Systems Tech raised its FY2025 sales guidance from $310.000 million-$315.000 million to $317.000 million-$321.000 million.“T ...